Document:

FISHER HEALTHCARE, A
DIVISION OF FISHER SCIENTIFIC COMPANY L.L.C. (“FISHER”) 

DISTRIBUTION AGREEMENT

(June 15, 2010 through May
31, 2012) (the “Initial Term”)

 

	 Supplier Information	 	Supplier #:	 

 

	Supplier Legal Name:     	Akers Biosciences,
    Inc.	 
	EIN #:	22-2983783	 
	State of Organization	New Jersey Corporation	 

 

	Address:     	201 Grove
    Road	     Contact:     	Name:	Thomas A.
    Nicolette
	 	Thorofare, New Jersey
    08086 USA	 	Title:	President and Chief Executive
    Officer
	 	 	 	E- Mail:	tan@akersbiosciences.com
	 	 	 	Phone:	856.848.2116
	 	 	 	Fax:	856.848.0269
	 	 	 	 	 

 

		1.	PRODUCTS,
                                                                                      INVENTORY AND WARRANTY

 

1.1          This
Agreement will cover all products sold by Supplier to Fisher (the “Products”). If Supplier develops similar or replacement
products Supplier will make those products available to Fisher under the terms set forth in this Agreement, (except for price
which will be agreed upon by Supplier and Fisher).

 

1.2          Fisher
will have the non-exclusive right to distribute the Products in the United States.

 

1.3          Fisher
will order Products by placing purchase orders and Supplier will fill those orders as set forth in this Agreement. Fisher and
Supplier acknowledge and agree that Supplier shall be required to fill any orders placed by Fisher pursuant to this Agreement
and that Supplier shall not have the right to decline such orders.

 

1.4          In
ordering and invoicing, Supplier agrees to use an electronic (EDI) system reasonably acceptable to Fisher.

 

1.5          If
Fisher agrees to stock the Products, Supplier agrees to accept returns or exchanges of saleable new Product inventory at full
acquisition cost with no restocking or handling fees if Fisher reasonably determines that sales are not sufficient to justify
inventory levels. SUPPLIER will accept returns of product in unopened, saleable, case quantities on a quarterly basis. In the
event of a return or exchange, Supplier agrees to pay all associated shipping costs, F.O.B. shipping point. Additionally, Supplier
agrees to repurchase from Fisher at full acquisition cost with no restocking or handling fees any saleable new Product inventory
at the time of termination or expiration of this Agreement, subject to Fisher’s post-termination needs set forth in Section
6.3 below. SUPPLIER will accept returns of product in unopened, saleable, full case quantities on a quarterly basis. Supplier
agrees to pay all associated shipping costs for returns and exchanges, F.O.B. shipping point. In addition, any Products owned
by Fisher and rendered unusable due to: (i) a change in any Product specification by Supplier or FDA, (ii) discontinuation or
elimination or recall by Supplier of any Product from its product offering, (iii) release by Supplier of any improved or updated
version of any Product or (iv) other cause listed in Attachment A, shall be repurchased from Fisher by Supplier within thirty
(30) days following Fisher's written request at full acquisition cost by Fisher. Supplier agrees to pay all associated shipping
costs for returns and exchanges, F.O.B. shipping point.

 

    	 

    	FISHER SCIENTIFIC COMPANY L.L.C. DISTRIBUTION AGREEMENT

    

 

1.7          Supplier
will provide to Fisher and its customer (as requested) current MSDS for all hazardous Products and product information as requested
by Fisher for proper regulatory classification. Supplier agrees to work in good faith with Fisher to provide the MSDS to Fisher
prior to the initial shipment of product to Fisher or its customers to which Supplier drop-ships. Current copies of product MSDS
are immediately available in the pertinent Product’s section of Supplier’s website under Literature.

 

1.8          Supplier
agrees to extend to Fisher and its customers no less than its standard warranty and product return policies.

 

1.9          In
the event of breach of any applicable warranty, Supplier will at Fisher’s discretion, (i) repair or replace the Product
at Supplier’s expense, or (ii) refund the purchase price, including any applicable shipping charges.

 

		2.	PRICING,
                                                                                      PAYMENT AND REBATES

 

The
purchase prices to be charged will be the net purchase price for the Products. These prices are outlined on Attachment A. The
quoted prices include all hazardous materials, refrigeration or other fees, charges or surcharges unless otherwise noted on the
attachment.

 

2.2          The
Attachment A pricing will remain fixed through December 31, 2011. After the expiration of the Firm Price Period, prices may be
increased no more than once in any contract year to be effective January 1 of the following calendar year. Supplier will provide
written notice of any proposed price increase at least 120 days prior to the effective date. Price increases will not exceed the
lesser of two percent (2%) per year or the annualized percentage change in Consumer Price Index (CPI) for all Urban Consumers
(Current Series) – U.S. All items Less Food and Energy – Series I.D.: CUUR0000SA0L1E at http://data.bls.gov/cgi-bin/surveymost?cu
for the previous 12 month period. New prices, once agreed upon, shall be firm and remain in effect until the next December 31,
unless otherwise agreed to. Shipments shall be billed at the price in effect at time of order placement. Notwithstanding the foregoing,
to the extent that Fisher cannot pass onto its contracted customers all or a portion of the price increase provided for in this
Section 2.2, Supplier and Fisher shall execute a cost recovery rebate agreement (substantially in the form attached hereto at
Exhibit C) providing a rebate to Fisher of any amounts that cannot be passed on to customer.

 

2.3          Shipments
will be billed at the price in effect at time of order placement. In the event of a price decrease, Supplier will provide Fisher
with a credit for the price reduction with respect to any on-hand inventory or in-transit inventory.

 

2.4          Supplier
agrees to negotiate in good faith with Fisher to provide special pricing on large quantities or where required in order for Fisher
to meet competition.

 

2.5          Payment
terms will be Net 45 days from the date of receipt of an accurate invoice. Notwithstanding the foregoing, Fisher will not be in
default if payments are paid within five (5) days of due date.

 

2.6          Supplier
agrees to pay to Fisher the Rebate/Growth Incentive described on Attachment A. Annual rebates will be paid to Fisher by March
31 of the following year. If Supplier does not make its rebate payment in a timely manner, Fisher will be permitted to auto-debit
Supplier’s account.

 

		3.	DELIVERY
                                                                                      AND TRANSPORTATION

 

3.1          Supplier
will ship the Products F.O.B. Destination point as designated by Fisher or its customer freight to be prepaid and absorbed by
Supplier. Unless otherwise stated on Attachment A, Supplier will not apply any additional fees or charges to Fisher for the shipment
of goods.

 

3.2          Supplier
will drop ship products that are utilized for user training and/or require packaging in dry ice directly to Fisher’s customers,
in accordance with the terms outlined in Attachment A.

 

    	Page 2

    	FISHER SCIENTIFIC COMPANY L.L.C. DISTRIBUTION AGREEMENT

    

 

3.3          Supplier
will take all necessary measures to ensure that PIFA Heparin/PF4 Rapid Assay devices are received by Fisher (or its customers)
with at least six (6) months of the remaining shelf-life. Supplier will take all necessary measures to ensure that Heparin/PF4
Antibody Serum Panels are received by Fisher (or its customers) with at least twelve (12) months of the remaining shelf-life.
Supplier will take all necessary measures to ensure that BreathScan products are received by Fisher (or its customers) with at
least eighteen (18) months of the remaining shelf- life. Products that do not conform with this requirement will be considered
to be defective.

 

3.4          Supplier
will ship to Fisher all Products ordered by Fisher within five (5) days of receipt of the purchase order so long as the order
size is consistent with historical levels provided by Fisher to Supplier. If the order size exceeds historical, Fisher and Supplier
will mutually agree on an acceptable delivery date.

 

		4.	SALES,
                                                                                      MARKETING AND TECHNICAL SUPPORT

 

4.1          Supplier
will engage in sales and marketing support as noted in Attachment C, Rules of Engagement.

 

4.2          Supplier
will provide to Fisher’s customers and sales personnel all reasonable technical support. If there are any spare parts necessary
for the operation and repair of the Products, Supplier will make those spare parts available to Fisher or its customers for a
reasonable period after delivery of the Products.

 

4.3          Supplier
will provide Fisher with electronic and hard copies of sales and marketing literature for reproduction or electronic distribution
by Fisher in the marketing, sale and distribution of the Products.

 

4.4          Supplier
will make demonstration materials available to Fisher’s customers for purchase from Fisher to assist Fisher with marketing
and sales of the Products.

 

		6.	MISCELLANEOUS
                                                                                      PROVISIONS

 

6.1          This
Agreement will be effective for the Initial Term stated in the heading of the Agreement. This Agreement will automatically renew
for successive twelve (12) month periods at Fisher’s option in its sole discretion provided Fisher hits certain targets,
as set forth on Attachment 1.3. In the event that Fisher does not hit such Targets, either party may give written notice of its
intent not to renew at least ninety (90) days prior to the expiration of the Initial Term and any renewal term. The Initial Term
and any renewal terms shall be collectively referred to as the “Term.”

 

6.2          Either
party may terminate this Agreement in the event of a material breach of by the other party. In such event, the non-breaching party
will provide thirty (30) days written notice of the breach and will provide an opportunity for the breaching party to cure the
breach during the notice period. Notwithstanding the foregoing, Fisher may terminate this Agreement immediately and without penalty
if Supplier has breached the provisions set forth in paragraph 20 (Compliance with Laws) of Attachment B hereto.

 

6.3          In
the event of termination or expiration of this Agreement, in the absence of contracts or other obligations between Fisher and
its customers that survive termination, Supplier agrees to continue to sell the Products to Fisher for a period of sixty (60)
days following termination of the Agreement. In the event that Fisher has customer commitments that survive beyond the termination
date of this agreement, Supplier will honor orders for Products necessary to fulfill the customer commitments on the terms and
condition applicable at the time of termination until the termination date of the customer commitments.

 

6.4          Any
term of this Agreement that contemplates survival beyond the term of this Agreement will remain enforceable in accordance with
its terms notwithstanding the termination or expiration of this Agreement.

 

6.5          Supplier
agrees that it will not use Fisher’s name, logo, or trademarks in any manner (including marketing materials, public announcements,
press releases, or similar communications) without the express written consent from Fisher.

 

    	Page 3

    	FISHER SCIENTIFIC COMPANY L.L.C. DISTRIBUTION AGREEMENT

    

 

6.6          This
Agreement specifically incorporates by reference the Procurement Terms and Conditions attached hereto as Attachment B as though
they were included in their entirety in this Agreement. This Agreement (including Attachment A) and the Procurement Terms and
Conditions comprise the entire agreement between the parties. In ordering and delivery of the Products, Fisher and Supplier may
use their standard forms, but nothing in those forms will in any way modify or amend the terms of this Agreement or the Procurement
Terms and Conditions.

 

	 	 	 	 	 
	Supplier Signature: 	 	 	Accepted by: 	Fisher Healthcare, a division
    of Fisher
	 	 	 	 	Scientific
    Company L.L.C.
	 	 	 	 	 
	Printed Name:	Thomas A. Nicolette	 	Signature:	 
	 	 	 	 	 
	Title:	President & Chief
    Executive 

    Officer, Akers Biosciences, Inc.	 	Printed Name: 	Joe Bernardo, President
	 	 	 	 	 
	Date:	11 JUNE 2010	 	Date:	11 JUNE 2010

 

    	Page 4

    	 

    

 

FISHER SCIENTIFIC
COMPANY L.L.C. DISTRIBUTION AGREEMENT 

ATTACHMENT 1.3 – TARGET ORDERS

 

Target
Orders. The Target Orders, for purposes of renewing the contract beyond the Initial Term, are set forth below represent the number
of cases of PIFA Heparin/PF4 Rapid Assay delivered to Fisher subsequent to Supplier’s receipt of Purchase Orders by December
31 of the corresponding Calendar Year (2012, for the Initial Term and then each calendar year thereafter):

 

30 Cases

 

    	 

    	FISHER SCIENTIFIC COMPANY L.L.C. DISTRIBUTION AGREEMENT

    

 

FISHER SCIENTIFIC
COMPANY L.L.C. DISTRIBUTION AGREEMENT

ATTACHMENT “A”

 

	Product
    and Discount Information	 

 

	Supplier
 Item
 Number	 	Material Description	 	Material Desc 2	 	Purchasing
 Order Unit	 	Acquistion
 cost	 	 	Min.
 Purchase	 
	 	 	 	 	 	 	 	 	 	 	 	 	 
	4036025	 	PIFA HEPARIN/PF4 Rapid Assay	 	Box = 6 PIFA HPF4 devices	 	Box	 	$	180.00	 	 	 	48	 
	4036027	 	Heparin/PF4 Antibody Serum Panel - 2 MEMBER 1POS/1NEG	 	DROP SHIP ONLY 2EA/BX	 	Box	 	$	39.00	 	 	 	1	 
	4036028	 	Heparin/PF4 Antibody Serum Panel - 6 MEMBER 5 POS/1 NEG	 	DROP SHIP ONLY 6EA/BX	 	Box	 	$	117.00	 	 	 	1	 
	3330047	 	Training KIT: 3-Device PIFA HEPARIN/PF4 Rapid Assay	 	DROP SHIP ONLY 3EA/BX	 	Box	 	$	90.00	 	 	 	1	 
	4000122	 	BREATHSCAN .02% Breath Alcohol DETECTOR	 	Box = 100 lab packs	 	Box	 	$	200.00	 	 	 	4	 
	4000124	 	BREATHSCAN .05% Breath Alcohol DETECTOR	 	Box = 100 lab packs	 	Box	 	$	200.00	 	 	 	4	 
	4000125	 	BREATHSCAN .08% Breath Alcohol DETECTOR	 	Box = 100 lab packs	 	Box	 	$	200.00	 	 	 	4	 

 

All
Drop Shipments to DISTRIBUTOR's customers by SUPPLIER will be made using DISTRIBUTOR’s UPS Freight Account Number.. SUPPLIER
will not charge any additional material or handling fees on DISTRIBUTOR invoices and DISTRIBUTOR will not request that SUPPLIER
provide any reimbursement for freight charges related to Drop Shipments.

 

	Rebate
    /Growth Incentives	 

 

Growth Rebate YOY:

 

Fisher will be entitled
to the growth rebate as set forth below (“Rebate”).

 

Fisher will measure
its SAC for each calendar year of the term of this Agreement and will compare the current year’s Sales at Cost (the “Current
SAC”) against the previous calendar year’s SAC (the “Previous SAC”). In the event that Fisher’s
Current SAC meets or exceeds the Previous SAC, Fisher will be entitled to a Growth Rebate calculated by multiplying the entire
Current SAC by the applicable percentage set forth in the following table:

 

	Current SAC	 	Applicable Growth Rebate
    Percentage	 
	>.2M	 	 	1.0	%
	0.2-1.0M	 	 	3.0	%
	$1.0M-2.0M	 	 	5.0	%
	2.0-2.5M	 	 	6.0	%
	>2.5M	 	 	7.0	%

 

By February 28 of each
calendar year, Fisher will invoice SUPPLIER for the Rebate.

 

    	Page 6

    	 

    

 

PROCUREMENT
TERMS AND CONDITIONS

ALL GOODS AND SERVICES
PROCURED BY FISHER HEALTHCARE, A DIVISION OF FISHER SCIENTIFIC COMPANY L.L.C, ITS AFFILIATES OR SUBSIDIARIES, (THE “BUYER”)
FROM AKERS BIOSCIENCES, INC. (“SELLER”) SHALL BE IN ACCORDANCE WITH THE FOLLOWING TERMS AND CONDITIONS

 

ATTACHMENT “B”

 

1. ACCEPTANCE. This Order is Buyer’s
offer to Seller (which term shall include subcontractors, independent contractors, and all other classes of persons performing
work hereunder) and shall become a binding contract on the terms and conditions set forth herein upon the earlier of (i) Seller’s
acknowledgement or (ii) by Seller’s full or partial performance hereunder. This Order does not constitute an acceptance
by Buyer of any prior proposal, quote or offer to sell, and any reference to such is solely for the purpose of incorporating the
description and/or specifications of the goods and services contained therein, but only to the extent that such description or
specification does not conflict with the description and specifications on the face of the Order.

 

2. COMPLETE AGREEMENT. This Order
and any underlying agreement between the parties on which this Order is based (the “Underlying Agreement”) and the
terms and conditions herein constitute the complete agreement between the parties and may not be altered or modified except in
writing duly executed by each party. Any additional terms or conditions contained in Seller’s order acknowledgment, or in
any other Seller document, shall be deemed objected to by Buyer without the need for further notice of objection, and shall be
of no effect, nor shall they be binding upon Buyer under any circumstances unless expressly accepted by Buyer in writing. Buyer’s
acceptance or rejection of one or more additional terms or conditions shall not constitute an acceptance of any other additional
term or condition. Trade custom, trade usage, course of dealing, and past performance are superseded by this Order and shall not
be used to interpret this Order.

 

3. CHANGES. Buyer shall have the
right to make changes to its order prior to receiving a Purchase Order Acknowledgement (EDI code 855) from Seller, including without
limitation, in the quantities, specifications, drawings, instructions, or delivery schedule. Any such change that has a significant
impact on Seller’s time or cost of performance shall entitle either Seller or Buyer to an equitable adjustment. However,
no additional charge will be allowed unless asserted by the Seller within five (5) business days after the change is ordered and
authorized by Buyer in writing. Information, such as technical direction or guidance provided to Seller by Buyer’s representatives
in connection with Seller’s performance hereunder, shall not be construed either as a change within the meaning of this
provision or as direction to proceed outside the scope of this Agreement.

 

4. CANCELLATION. Buyer may cancel
this Order in whole or in part upon notice to Seller in writing or via EDI, within one (1) business day of Buyer’s receipt
of Purchase Order Acknowledgment, without liability to Buyer.

 

5. NO PUBLICITY. Seller shall not
issue or cause to be issued any press release, public announcement or disclosure of any kind or nature whatsoever or otherwise
disclose the existence of the transactions contemplated hereby except as and to the extent that both parties jointly agree to
such press release, public announcement or disclosure previously and in writing.

 

6. DELIVERY. TIME IS OF THE ESSENCE
for delivery to Buyer hereunder. Seller shall promptly provide written notification to Buyer of any possible or actual delay in
performance hereunder and shall provide all relevant information concerning the cause for such delay. In no event, however, shall
such notice relieve Seller of its obligations under this Order. If delivery is not made within the time specified, Buyer may purchase
elsewhere and charge Seller any difference in price and/or Buyer may cancel the entire order or any undelivered portion thereof.
Payments due to Seller may be offset against sums owed to Buyer by Seller. Deliveries shall be strictly in accordance with the
schedule set out or referred to in the Order and in the exact quantities ordered. In no event shall Buyer be liable for any excess
goods shipped by Seller. Buyer reserves the right at Seller’s expense to return goods shipped not in accordance with Buyer’s
order set forth on the face hereof. Notwithstanding anything to the contrary set forth in the Agreement or in this Attachment,
Seller hereby agrees that it shall not have the right to decline to fill any order submitted by Fisher in accordance with this
Agreement.

 

7. WARRANTY. Seller warrants and
guarantees that its goods and services (collectively "Products"): (a) will comply with all relevant specifications and
requirements; (b) will be of merchantable quality, free from any latent or patent defects; (c) will be safe and fit for their
intended use; (d) shall reference true weights, measures, sizes, legends or descriptions indicated; (e) will be of comparable
quality as all samples delivered to Buyer, if any; and (f) shall comply with all applicable laws, rules, regulations, licenses,
permits, ordinances, codes and or standards. This warranty and guaranty shall be in addition to any statutory or implied warranties,
and warranties of broader scope and service warranties and guarantees given to Buyer by the Seller, and shall survive inspection,
test, acceptance, and payment, and shall run to Buyer, its successors, assigns, and customers.

 

8. NONCONFORMANCE. Buyer will immediately
notify the Seller’s Quality Control (QC) Department, in writing, upon discovery thereof, of any products that in the Buyer’s
opinion do not conform to the requirements of this Order. All nonconformance inquiries that originate from Buyer’s customers
will be handled by Buyer’s customer service organization in accordance with Buyer’s Returned Goods Policy. Once contacted
by Buyer, Seller’s QC Department will provide Buyer with a Return Goods Authorization Number ("RGA Number"). This
number must be referenced on return shipping documents. Seller will arrange to have said Product shipped to Seller, at the Seller’s
expense, for further analysis by the Seller’s QC Department.. All costs with respect to the repair, replacement or refund
of the Products that are confirmed to be nonconforming by Seller, including packing, packaging and freight charges, shall be at
the Seller’s expense. In the event of a dispute between Seller and Buyer as to the conformity of the Product, the Parties
shall engage an independent third party laboratory to resolve same within 30 days of the initial nonconformance inquiry and such
third party’s decision shall be final and binding on the Parties.

 

9. PROPRIETARY RIGHTS. Seller hereby
acknowledges that Buyer is the owner of the trademarks and trade names connoting Buyer or Buyer products which it may elect to
use in the distribution and sale of the Products, and that Seller has no right or interest in such trademarks and trade names.
Seller agrees that it will not use Buyer's name, trade name or trademark in any way without the prior express written consent
of Buyer. Seller hereby grants to Buyer the royalty-free license to use Seller's trademarks on the Products, it being expressly
understood that if Buyer elects to use Seller's trademarks during the term of the Agreement, Buyer shall properly do so by acknowledging
Seller as the owner of such trade names or trademarks and shall discontinue the use of such trademarks in any new material published
after the termination hereof. Following the termination of this Agreement, Seller grants to Buyer the right to continue to use
Seller's trademarks as necessary in connection with the sale or service of Products purchased by Buyer during the term of this
Agreement. Seller represents and warrants that it maintains all rights of ownership or use in any trademark, patent, copyright
or any other Intellectual Property necessary to sell the Products to Buyer pursuant to this Agreement ("Intellectual Property"),
and that the use by Buyer of any Intellectual Property pursuant to this Agreement will not conflict with or infringe upon the
rights of any third party.

 

10. EQUIPMENT & SPECIAL TOOLING.
Buyer shall not be obligated to reimburse Seller for the cost of any equipment or tooling unless specifically agreed to in writing
by Buyer. Any equipment, tools, jigs, dies, fixtures, templates, patterns, or drawings (hereinafter collectively called "tools")
furnished by Buyer to Seller and any tools made or acquired by Seller for the performance of Buyer's order, the cost of which
is separately quoted or advertised in the unit price, shall remain or become the property of Buyer. All such tools shall be used
exclusively for production under Buyer's orders. Reproducible drawings for tools to be made or acquired by Seller for performance
of Buyer's orders shall be submitted to Buyer for approval or to the manufacturer for acquisition of such tools. Seller will maintain
the tools in first-class condition and will make replacements when necessary. Seller will not make any alterations to such tools
without Buyer's specific written authorization. Seller will be responsible for all loss or damage to such tools while in Seller's
possession. Upon completion or cancellation of this order, such tools shall be disposed of as Buyer shall direct.

 

11. WORK ON BUYER’S PREMISES.
Where Seller is required to enter premises occupied by Buyer or under Buyer’s control to perform services or otherwise,
Seller will inspect the premises involved, will provide all necessary safeguards for persons it brings on to the premises, will
defend, protect, indemnify and hold Buyer and its successors, assigns and employees harmless from and against all claims, losses,
expenses, damages and liabilities, direct, incidental or consequential arising from damage to or loss of property by Seller, its
employees or others, or from personal injuries to or death of Seller, Seller’s employees or others resulting from or incidental
to the presence of such persons on the premises involved WHETHER THE SAME RESULTS IN WHOLE OR IN PART FROM BUYER’S NEGLIGENCE
OR OTHER FAULT BY ACT OR OMISSION, OR THAT OF BUYER’S EMPLOYEES OR OTHERWISE, IT BEING THE INTENT OF THIS PROVISION TO ABSOLVE
AND PROTECT BUYER AND ITS SUCCESSORS, ASSIGNS AND EMPLOYEES FROM ANY AND ALL LOSS BY REASON OF SELLER’S PERFORMANCE OF WORK
ON BUYER’S PREMISES, and will maintain workmen’s compensation insurance covering all employees performing services
related to this order on premises occupied by Buyer or under Buyer’s control. Seller expressly agrees to waive any provisions
of the applicable workers compensation law, whereby Seller could preclude its joinder as an additional defendant or avoid liability
for damages, contribution or indemnity.

 

12. RIGHT-OF-ACCESS. Buyer reserves
the right, during normal business hours, and with a two (2) business day notice, to verify purchased Products at Seller’s
premises and to inspect Seller’s work hereunder to ensure that all relevant standards and specifications are met. Any such
inspection by Buyer does not absolve Seller of the responsibility for the quality of Products, nor shall it preclude subsequent
rejection by Buyer.

 

    	 

    	FISHER SCIENTIFIC COMPANY L.L.C. DISTRIBUTION AGREEMENT

    

 

13. PACKING & SHIPPING. No
charge shall be allowed for handling, packing, crating, drayage or storage without written permission of Buyer and/or as outlined
in Attachment A of this Agreement. Goods shall be packaged in a method to preserve and protect from damage and/or degradation,
and shall be suitably prepared for shipment by Seller in accordance with acceptable commercial practices and in compliance with
all applicable laws. Seller shall cause the goods to be labeled and marked to conform to all requirements of all applicable federal,
state and local laws, including but not limited to CE markings. Seller shall identify Buyer’s purchase order number on Seller’s
invoice, packing list, bill of lading or on any packages. Seller shall attach an invoice to all shipments, in addition to forwarding
a copy of such invoice to Buyer.

 

14. PRICING. This Order must not
be filled at prices higher than last quoted by Seller or as set forth in the Underlying Agreement unless Buyer consents in writing.
Seller represents that the prices to be paid or otherwise charged to Buyer are not any higher than the lowest price for such goods
or services offered by Seller to any other of its customers, excluding United States government entities. Seller shall be responsible
for and pay all federal, state, and local sales, use, income, excise, property, employment, and other taxes similar to, or differing
from, any of the foregoing, incurred or levied on or in connection with the manufacture of goods, provision of services, or relating
to Seller’s own property. Buyer shall be responsible only for taxes arising from its ownership of the Products. Seller agrees
to indemnify Buyer against any loss, liability or expense (including reasonable attorneys fees) resulting from Seller’s
failure to pay such taxes, fees, duties, assessments, charges or conditions.

 

15. TITLE. Seller warrants full,
unrestricted title to all goods and services furnished hereunder, free and clear of all liens, security interests and encumbrances.
Care, custody and control of, and title to all Products remain with Seller until such time as Buyer takes physical possession
or otherwise agrees in writing. Seller shall carry on its work and manufacture of Products at its own risk until the Products
are completed and accepted by the Buyer. In the case of accident, destruction or injury to the Products before the Buyer’s
final completion and acceptance, Seller shall repair or replace such Products at its own expense and to the Buyer’s satisfaction.

 

16. HAZARDOUS MATERIALS. Seller
will notify Buyer in writing upon acceptance of this Order if Products furnished are subject to laws or regulations relating to
hazardous or toxic substances, whether for shipment or use, or when disposed of, to regulations governing hazardous wastes, or
any other applicable environmental, health, or safety laws or regulations. Instructions for shipping, handling, warnings, and
material safety data sheets shall be provided with each shipment. Seller shall submit to Buyer, prior to the initiation of shipments
to Buyer or Buyer’s customer to which Seller drop ships, a copy of all relevant MSDS sheets. Seller agrees to and shall
accept, at its facility, all of Buyer’s unsold or expired Products containing hazardous chemicals, materials or substances
for disposal, recycling or use. Buyer shall be responsible for packing and transportation costs to Seller. Seller shall be responsible
for all other costs, including, without limitation, any costs associated with Seller's disposal, recycling or use.

 

17. PATENTS. Seller warrants that
the manufacture, use and sale of the Products do not infringe any claims of any patent, trademark, trade name, copyright or any
other third-party property right. Seller agrees to defend, indemnify and hold Buyer (and its agents, representatives, employees,
officers, directors, affiliates, successors, assigns, and customers) harmless from any and all claims, demands, actions, damages
and liabilities (including legal fees) involving the infringement of any third-party patent, trademark, copyright or other intellectual
property right, or the misappropriation of any trade secret, by reason of the manufacture, use, or sale of said Products by Buyer.
Without limiting the foregoing, if any of the Products becomes, or in Buyer’s opinion, may become the subject of any claim,
suit or proceeding for infringement of any patent, Seller will, at Buyer’s option and at Seller’s sole expense, (i)
obtain for Buyer the right to use, lease or sell the Product, (ii) replace the Product, (iii) modify the Product, or (iv) remove
the Product and refund the full purchase price paid by Buyer

 

18. INDEMNITY & INSURANCE.
Seller agrees to defend, indemnify and hold Buyer (and its agents, representatives, employees, officers, directors, affiliates,
successors and assigns, customers, and all subsequent users of the Products) harmless from all claims, demands, actions, damages,
and liabilities (including reasonable attorney’s fees) in any way connected with the goods or services provided to Buyer
hereunder, the breach of any of the terms and conditions contained herein, or any act or omission of Seller, its agents, employees,
or subcontractors. Should Seller deem that a recall be necessitated due to a defect or non-conformance of the Products, Seller
shall bear all pre-approved costs and expenses of such recall, detailed in writing by Seller, including without limitation, costs
of notifying customers, returning Products, customer refunds, lost profits, and any expenses incurred to meet obligations to third
parties. Buyer agrees to assist Seller in conducting the recall in a timely manner in accordance with the Guidelines set forth
in Title 21 C.F.R. (Food & Drugs). Seller agrees to procure and maintain on an occurrence form basis product liability insurance
with respect to the Products and contractual liability coverage relating to the Underlying Agreement, if any, with insurer(s)
having Best's rating(s) of A- or better, naming Buyer as an additional insured (Broad Form Vendors Endorsement), with minimum
limits in each case of $2,000,000. Seller shall promptly furnish to Buyer a certificate of insurance and renewal certificates
of insurance evidencing the foregoing coverages and limits. The insurance shall not be canceled, reduced or otherwise changed
without providing Buyer with at least thirty (30) days prior written notice.

 

19. LIMITATION OF LIABILITY. IN
NO EVENT SHALL BUYER BE HELD LIABLE FOR PUNITIVE, EXEMPLARY, SPECIAL, INDIRECT, INCIDENTAL OR CONSEQUENTIAL DAMAGES, UNLESS DAMAGES
WERE LEGALLY DETERMINED TO BE CAUSED BY THE FAULT OR NEGLIGENCE OF BUYER. Buyer’s liability on any claim of any kind for
any loss or damage arising out of or in connection with this Order or from the performance or breach thereof shall in no case
exceed the price allocable to the Products ordered and delivered hereunder. Any action resulting from any alleged breach by Buyer
must be commenced within one year after the cause of action has accrued, or Seller shall be deemed to have waived any such claims.

 

		20.	COMPLIANCE WITH
                                                                                LAWS.

(a)
Seller shall comply with all applicable international, federal, state, county, and municipal statutes, laws, regulations, codes,
standards, ordinances and orders in its performance hereunder and shall be responsible for all fees associated with such compliance,
licenses, permits, certifications, bonds, taxes, duties, tariffs and other applicable fees. Without limiting the foregoing, Seller
will comply with all applicable customs laws and requirements of the U.S. (including specifically the U.S. Export Administration
Act) and of each country in which the Products are made or likely to transit with respect to (a) the labeling of the Products
and their packaging, (b) the export and import of the Products and the subsequent distribution of the Products to Buyer and/or
directly to the Buyer’s customers, including the completion and submission of all required documentation, and the payment
of all taxes, duties, tariffs and similar expenses. In addition, Seller hereby acknowledges, represents and warrants (i) that
Seller WILL NOT provide any Products that in whole or in part have been transferred, exported or imported, directly or indirectly,
from a country or nation thereof, subject to restrictions under applicable laws and regulations, including but not limited to
inclusion on the Export Administration Regulations’ Denied Party List or any similar list published by a United States or
foreign agency; (ii) Seller is not located in, under the control of, or a national resident of any such restricted country; (iii)
the Products have not been produced, in whole or in part, by prison labor, sweatshop labor, abusive forms of child labor, slave
labor, or by other labor practices in violation of applicable law; and (iv) unless otherwise agreed to in writing by Buyer and
Seller, Seller shall serve as the Importer of Record for the Products and shall comply with all applicable laws, be responsible
for all applicable fees, and assume all obligations incurred as the Importer of Record.

 

(b) U.S.
Food & Drug Administration (FDA) Compliance: Seller shall comply with all aspects of the FDA Regulations as detailed in
Title 21 C.F.R. (Food & Drugs) § 1-1499. Without limiting the foregoing, Seller specifically agrees to the following:

 

(i) Seller
shall ensure proper registration of all establishments and products involved in the development, manufacture and distribution
cycles of the Products and shall comply in all respects with any laws relating thereto.

 

(ii)
Seller shall register and remain registered with FDA as the Specification Developer and the Manufacturer of the products and
will serve as the Importer of Record under U.S. Customs and Border Protection laws.

 

(iii)
Seller shall register with FDA all Foreign Establishments manufacturing FDA-regulated Products according to the applicable
laws and regulations and hereby agrees to perform routine audits of such Foreign Establishments during the term of this
Agreement. Seller shall ensure that all Medical Devices produced in their establishment(s) are listed with the FDA and
conform to regulations pursuant to FDA Federal Code of Regulations (C.F.R.) Title 21, Subpart H, Part 807.

 

(iv)
All Products quality issues, Medical Device Reporting, reports of corrections and removals and Medical Device Tracking must
be performed in a timely manner by Seller and as required by federal laws and regulations with appropriate notice provided to
Buyer. Without limiting the foregoing, Seller shall promptly acknowledge receipt of all Product Improvement Reports submitted
by Buyer and shall take all necessary and appropriate corrective action deemed appropriate by Seller’s QC
Department.

 

(v)
Seller must assure that any Products requiring sterilization comply with all applicable law and Good Manufacturing Practices,
as defined by FDA regulations.

 

(vi)
Seller will maintain all required documentation as mandated by FDA regulations and as required pursuant to Seller’s
Quality System. Additionally, Seller will comply with and will maintain a process to document such compliance in accordance
with the Quality System Regulations (21 C.F.R. § 820). Seller will make any and all such documentation available for
review by Buyer (or its designee) pursuant to the terms of this Agreement.

 

    	Page 8

    	FISHER SCIENTIFIC COMPANY L.L.C. DISTRIBUTION AGREEMENT

    

 

(vii)
Seller will cooperate with Buyer to allow Buyer (or its designee) to audit Seller or any of Seller’s manufacturers in
the supply chain as needed and upon request in compliance with this Agreement given five (5) business days notice.

 

(viii)
With respect to any labels and packaging (including specifically any Instructions for Use and packaging inserts), Seller
verifies that all such labels and packaging if required by law, is approved in advance by the FDA.

 

(ix)
With respect to process changes, Seller will communicate to Buyer, in a timely manner, any raw material, formulation or
process change that significantly alters the product design or function.

 

(x) Seller
shall be responsible for distributing any customer notifications required by law. Seller shall coordinate such distribution with
Buyer’s Quality and Regulatory Departments. Examples of such required communication would be: (i) quality issues, (ii) process
changes, (iii) recalls, (iv) Medical Device Reporting, (v) reports of corrections and removals, and (vi) Medical Device Trading.

 

(xi) Seller,
as the Specification Developer and Manufacturer will be responsible for notifications, as required, to FDA pursuant to 21 C.F.R.
§ 1-1499.

 

(xii)
Notwithstanding the foregoing, in the event that the Products are manufactured or transported by Seller in such a way that
another country’s equivalent of the U.S. FDA may have jurisdiction, Seller agrees that it will comply with any such
laws and regulations which relate in any way to the marketing, manufacture, distribution or transportation of the
Products.

 

21.
ASSIGNMENT. Seller shall not assign this Agreement or any rights or work performed hereunder without the prior written
consent of Buyer. Any attempted assignment without such consent shall render this Agreement null and void.

 

22. WAIVER. No
failure to exercise, and no delay in exercising, on the part of Buyer any right, power or privilege hereunder will operate as
a waiver, nor will any single or partial exercise of any right, power or privilege preclude further exercise of the same
right, power or privilege.

 

23. VALIDITY
OF PROVISIONS. In the event that any provision or any part or portion of any provision of this Order shall be held to be
invalid, void or otherwise unenforceable, such holding shall not affect the remaining parts or provisions hereof.

 

24.
GOVERNING LAW & VENUE. This Agreement shall be governed in accordance with the laws of the State of Pennsylvania,
without reference to any conflict of law provisions; provided, however, that Seller’s liability for any harm caused by
the Products shall be governed by Chapter 82 of the Texas Civil Practice & Remedies Code (the “Texas Code”).
Unless the parties agree otherwise in writing, the state and federal courts located in Alleghany County, Pennsylvania shall
have exclusive jurisdiction over all disputes hereunder, and the parties hereby consent to such jurisdiction, agree to accept
service process by mail, and hereby waive any jurisdiction or venue defenses otherwise available. The parties agree the UN
Convention on Contracts for the International Sale of Goods shall not apply to the sale of goods hereunder.

 

25.
CONFIDENTIALITY. Seller expressly agrees to hold as confidential any information which is provided by Buyer
("Confidential Information"). Seller expressly acknowledges and agrees that Buyer's customer names, addresses, key
contacts, customer purchase history, documents and information in any way related to the marketing, sale, pricing or
distribution of any products are and shall be the Confidential Information of Buyer, regardless of whether such information
is expressly marked as "confidential" by Buyer. Additionally, Seller hereto acknowledges and agrees that the
existence and nature of this Agreement shall constitute Confidential Information. Seller agrees that it will limit the
Confidential Information that it provides to Buyer to information concerning sources, new products development and financial
information unless Buyer consents to the disclosure of additional information. In the event Confidential Information is
exchanged according to these guidelines, such information will be retained by the Seller in confidence during the term of
this Agreement and for a period of five (5) years following the termination of this Agreement. The transmittal of such
information is and shall be upon the express condition that the information is to be used solely to effectuate this
Agreement; and the Seller shall not use, publish, or disclose said information, in whole or in part, for any purpose other
than that stated herein. Notwithstanding the foregoing, the above restrictions on disclosure and use shall not apply to any
information which the Seller can show by written evidence, was known to it at the time of receipt, or which may be obtained
from third parties who are not, to the Seller's knowledge, bound by a confidentiality agreement to the Buyer, or which is in
the public domain, or which may be independently developed without use of the Confidential Information.

 

26.
GRATUITIES. Neither the Seller, nor anyone in privity with the Seller, shall have accepted or accept, or give or agree to
give, any gratuity from any person, including but not limited to the Buyer, in connection with the purchase of Products.

 

27.
NON-SOLICITATION. During the term of any Underlying Agreement and for one (1) year after termination of the Underlying
Agreement or after placement of the Order (as applicable) (the "Restricted Period"), Seller, whether for its own
account or the account of any other person or entity at any time, shall not, directly or indirectly, solicit for employment,
any person who is (or was during the Restricted Period) an employee or agent of Buyer, or in any manner, directly or
indirectly, induce or attempt to induce any employee of Buyer to terminate his or her employment with Buyer.

 

28. AUDIT
RIGHTS. During the term of the Underlying Agreement or for a reasonable period after placement of the Order or
termination of the Underlying Agreement, Buyer shall have the right upon reasonable notice and during normal business hours,
with five (5) business days notice, to audit the facilities and records of Seller as reasonably necessary and as subject to
any existing confidentiality agreements in order to ensure compliance with the terms of the Underlying Agreement and these
Terms and Conditions; provided that Buyer will use commercially reasonable efforts to minimize any inconvenience to Seller as
a result of such audit.

 

If the end user
of the Products or Services will be a federal, state or local government or municipality or similar party, the following provisions
will apply:

 

29.
GOVERNMENT PROCUREMENT PROVISIONS. If the Products to be furnished by Seller are to be used in the performance of a U.S.
government contract or subcontract, those clauses of the applicable U.S. Government procurement regulation which are required
and mandated by Federal Statute to be included in U.S. Government subcontracts shall be incorporated herein by reference
including, without limitation, the Fair Labor Standards Act of 1938, as amended, and the provisions of Executive Orders Nos.
11246, 11701 and 11758, the Rehabilitation Act of 1973, the Vietnam Era Veterans Readjustment Assistance Act of 1974, and all
applicable amendments thereto and rules and regulations issued hereunder. Upon Buyer’s request, Seller will promptly
provide certification to evidence the country of origin of such materials purchased hereunder. Seller shall indemnify Buyer
for any loss, liability, or expense resulting from Seller’s failure to properly comply with Seller’s requirements
or applicable laws or regulations regarding country of origin, including but not limited to the Berry Amendment, where
applicable.

 

If the end user
of the Products or Services will in any way relate to the federal healthcare programs, the following provision will apply:

 

30.
HEALTHCARE REPRESENTATIONS. The Office of Inspector General (“OIG”) Special Advisory Bulletin on the Effect
of Exclusions on Participation in Federal Health Care Programs clarifies the OIG’s sanction authority to impose civil
money penalties and deny reimbursement under federal health care programs of any and all products or services if products or
services are provided by an excluded entity. (Federal Register, September 30, 1999, Vol. 64, No. 189, pp. 52791-52794.) The
OIG Special Advisory Bulletin specifically provides that “items or equipment sold by an excluded manufacturer or
distributor, used in the treatment of beneficiaries and reimbursed, directly or indirectly, by a federal health care program
violate the OIG’s exclusion.” Seller represents and warrants that neither it, any of its subsidiaries or
affiliated businesses, nor any officers, directors, or other key personnel of same, have been (a) convicted or threatened
with conviction of any health care related offense, whether state or federal, or (b) been or threatened with being debarred,
excluded, or otherwise listed or rendered ineligible for participation in any federal or state healthcare program, as that
term is defined by 42 USC §1320a-7b(f) by any state or federal agency (collectively referred to herein as being
“Excluded”). If Seller, any of its subsidiaries or affiliated businesses, or any officers, directors, or other
key personnel of same, are Excluded or otherwise receive from authorities a notice of intent to Exclude from federal or state
healthcare program participation, Seller shall immediately notify Buyer of the same in writing within forty-eight (48) hours.
Upon notice of same, Buyer shall have the right to immediately terminate this Order or the Underlying Agreement in its sole
discretion without cost or penalty. In the event Seller breaches or otherwise fails to comply with any provision of
this Paragraph, Seller hereby agrees to defend, indemnify and hold Buyer harmless from and against any loss, claim, suit,
expense or obligation arising out of or resulting from any such breach or noncompliance, including, but not limited to,
sanctions, penalties, or fines incurred under the federal Civil Monetary Penalty Law (Section 1128A of the Social Security
Act), the Health Insurance Portability and Accountability Act of 1996 or the Balanced Budget Act of 1997.

 

    	Page 9

    	 

    

 

AMENDMENT

 TO

DISTRIBUTION AGREEMENT

BETWEEN

AKERS BIOSCIENCES, INC.

AND

FISHER HEALTHCARE

 

THIS AMENDMENT TO THE DISTRIBUTION AGREEMENT
("Amendment") is made and entered into effective as of May 1, 2012
(Effective Date"), by and between Akers Biosciences, Inc. ("Supplier") and Fisher HealthCare,
an unincorporated division of Fisher Scientific Company, L.L.C. ("Fisher HealthCare"). Supplier and Fisher HealthCare
are each sometimes referred to herein individually as "Party" and collectively as the "Parties".

 

RECITALS:

 

WHEREAS,
the Parties executed a Distribution Agreement effective June 15, 2010 (the "Agreement");

 

WHEREAS,
Supplier per letter dated April 12, 2012 desires to rescind Supplier's letter dated February 22, 2012 terminating the
Agreement; and

 

WHEREAS,
Supplier and Fisher HealthCare each desire to amend the Agreement upon the terms and conditions agreed to herein.

 

NOW, THEREFORE,
for the consideration described herein, the Parties agree to amend the Agreement as follows:

 

		1.	Supplier's letter dated April 12, 2012 is hereby rescinded and of no force and effect and the Initial Term shall be amended
as follows:

 

The Initial Term set forth at the top of the first
page of the Agreement shall be extended to May 31, 2014. The Initial Term shall automatically renew for successive twelve (12)
month periods as set forth in Section 6.1 of the Agreement.

 

		2.	Attachment A to Distribution Agreement. Attachment A shall
                                                          be amended to reflect the pricing for the Products set forth below:

 

ABI Item # 4036025             Price $208

ABI Item #4036027               Price $45

ABI Item #4036028              Price $135

 

		3.	Defined Terms and References. All capitalized terms used herein that are not defined herein shall have the same respective
meanings ascribed to such terms in the Agreement. All references to Articles, Sections, Paragraphs and Exhibits are to corresponding
Articles, Sections, Paragraphs and Exhibits of the Agreement.

 

		4.	Amendment. This Amendment may be amended or supplemented only by an instrument in writing executed by the parties hereto.
Except as specifically amended hereby, the Agreement shall continue in full force and effect and is hereby ratified by all parties
thereto.

 

		5.	Parties Bound. This Amendment shall be binding
upon and inure to the benefit of the parties hereto and their respective successors and
legal representatives. Each Party represents and warrants that it has the authority to sign in their respective capacity as contemplated
hereby.

 

    	 

    	 

    

 

		6.	Conflicts. In the event that any conflict is determined to exist between a term or provision of this Amendment and a
term or provision set forth in the Agreement or in any other document, it is understood and agreed that this Amendment shall control
and govern the construction and interpretation of such term or provision.

 

		7.	Facsimile/Countemarts. This Amendment may be executed in
                                                          counterparts and by facsimile signatures and such counterparts shall
                                                          together constitute one enforceable document.

 

		8.	No Oral Agreements. THE AGREEMENT, AS MODIFIED
                                                                 BY THIS AMENDMENT, REPRESENTS THE FINAL AGREEMENT BETWEEN THE
                                                                 PARTIES AND MAY NOT BE CONTRADICTED BY EVIDENCE OF PRIOR, CONTEMPORANEOUS,
                                                                 OR SUBSEQUENT ORAL AGREEMENTS OF THE PARTIES.

 

IN WITNESS WHEREOF, this Amendment has been executed
as of the Effective Date.

 

	FISHER HEALTHCARE, an	 	AKERS BIOSCIENCES, INC.
	unincorporated division of Fisher Scientific Company, L.L.C.	 	 
	 	 	 
	By:	 	 	By:	/s/ Thomas a. Nicolette
	Name:	 	 	Name:	THOMAS A. NICOLETTE
	Title:	 	 	Title:	PRESIDENT AND CEONATIONAL
BRAND DISTRIBUTION AGREEMENT

 

This Agreement, effective May 1, 2007 (“Effective
Date”), is between Akers Biosciences, Inc., a New Jersey corporation with its principal offices located at 201 Grove Rd.,
Thorofare, New Jersey 08086, hereinafter called "SUPPLIER," and Cardinal Health 200, Inc. a Delaware Corporation that
is the Medical Products and Services Group of Cardinal Health, with offices located at 1450 Waukegan Road, McGaw Park, Illinois
60085, hereinafter called "DISTRIBUTOR."

 

BACKGROUND

 

SUPPLIER manufactures and/or markets certain
products (specifically, the “Products” as defined in Section 1 below). SUPPLIER desires to appoint DISTRIBUTOR as an
authorized DISTRIBUTOR of the Products and DISTRIBUTOR desires to accept such appointment on the terms and subject to the conditions
described in this Agreement.

 

SUPPLIER and DISTRIBUTOR agree as follows:

 

1.          Products
Covered by this Agreement. The products covered by this Agreement are those products manufactured by SUPPLIER bearing a
SUPPLIER owned trademark and listed on Schedule "A" (the “Products”), all of which are identified herein
by DISTRIBUTOR catalog number, together with the parts and components necessary for the repair and replacement thereof, and all
modifications, improvements, and developments pertaining to such products, accessories and components. Products may be added to
or deleted from this Agreement by mutual consent of the parties.

 

2.          Grant
of Distributorship. SUPPLIER hereby appoints DISTRIBUTOR as an exclusive distributor in the USA of the PIFAâ
Heparin / PF4 Rapid Assay (#4036025) and Serum Panel (#4036027, #4036028) Products and DISTRIBUTOR accepts such grant for the term
and on the conditions stated in this Agreement. SUPPLIER agrees that it shall not, during the term of this Agreement, solicit interest
from or negotiate with Thermo Fisher Scientific regarding the sale of the Products for resale or sell the Products to Thermo Fisher
Scientific. DISTRIBUTOR agrees that, during the term of this Agreement, the Products shall be included on its master merchandise
file and categorized as National Brand. SUPPLIER acknowledges and agrees that DISTRIBUTOR has no marketing or promotional obligations
with regard to the Products and that DISTRIBUTOR is not prohibited from using, selling or promoting any products which are competitive
with the Products, to include its Best Value Product offering.

 

3.          Term
and Renewal. The term of this Agreement shall begin on the Effective Date and shall continue until terminated in accordance
with the provisions of Section 8 below.

 

4.          Pricing
and Payment Terms

 

a.           The
prices for Products ordered by the DISTRIBUTOR shall be as set forth on Schedule A. All such prices shall remain firm until December
31, 2007. SUPPLIER agrees to abide by DISTRIBUTOR’s then-current “Supplier Price Change and Notification Policy”,
a current copy of which SUPPLIER acknowledges receiving prior to the execution of this Agreement.

 

b.           Terms
of payment are 2%/30 days, net 31 days from DISTRIBUTOR’s receipt of Product.

 

c.           DISTRIBUTOR
shall deduct an administrative fee of 3% at time of invoice payment to cover the costs of trace sales reporting, the rebate process,
contract administration, master merchandise file costs and other costs to administer the procurement of inventory and other associated
processes. The trace sales report shall be provided on a monthly basis.

 

d.           If
SUPPLIER approves adjusted cost contracts for specific customer then SUPPLIER agrees to the following process with regard to rebates:
DISTRIBUTOR uses an auto-debit system where rebate dollars are automatically deducted from a supplier’s payables balance
upon the sale to the end-user customer. Rebate dollars are accumulated until a specified time period (usually one month) and then
the deduction is made. A remittance advice will follow showing which deductions have been made.

 

    	NATIONAL BRAND DISTRIBUTION AGREEMENT	1	 

    	 

    

 

5.          DISTRIBUTOR's
Duties

 

DISTRIBUTOR shall:

 

a.           Upon
customer request, offer the Products as a part of its generally available distribution offering and provide non-technical distribution
support for the Products to its customers.

 

b.           Submit
its order for Products via EDI transaction (see Section 6.c.i. below) on its standard purchase order form the terms and conditions
of which are incorporated herein by reference thereto to the extent such terms and conditions do not conflict with the terms and
conditions of this Agreement. To the extent there is such a conflict, the terms and conditions of this Agreement shall control.

 

c.           Pay
for such orders in accordance with the payment terms specified in Section 4 above.

 

d.           Participate
with SUPPLIER in business reviews, as mutually agreed by the parties.

 

e.           Provide
a sales tracing report on a monthly basis . 

 

f.           Maintain
complete and accurate records for such periods as may be required by applicable law, of all the Products sold by it.

 

g.           Designate Products on the attached Schedule “A”
as Focus Products for FY2007 and FY 2008

 

h.           Ensure
field force, including sales management, has adequate training on the product(s) and is engaged in actively selling a Focus Product
during the term of the Focus Program. 

 

i.            Provide quarterly updates to sales rep roster for
new representatives and allow SUPPLIER to train new hires on Focus Product(s) via phone and/or direct mail periodically.

 

6.          SUPPLIER's
Duties

 

SUPPLIER shall:

 

a.           Promptly
ship to all DISTRIBUTOR Distribution Centers, F.O.B. Destination. It is understood that SUPPLIER’s pricing for the Products
purchased by DISTRIBUTOR includes transportation expenses. All Direct (Drop) shipments to DISTRIBUTOR's customers by SUPPLIER must
be F.O.B.Destination, Prepaid and Add. DISTRIBUTOR reserves the right to determine the carriers to be selected for shipment to
its customers. Any deviation from these terms must be agreed upon prior to shipment by both SUPPLIER and the DISTRIBUTOR's Transportation
Department, McGaw Park, IL.

 

b.           Use
best efforts to maintain 98% Fill Rate (defined below) on all orders for Products. Fill Rate is defined as complete line items
shipped within 48 hours of receipt of DISTRIBUTOR’s purchase order.

 

c.           In
addition to any electronic data interchange (EDI) transactions which are required under DISTRIBUTOR’s “Supplier Price
Change & Notification Policy”, maintain the systems necessary and utilize the following:

			i.            Purchase Order (EDI #850): Transmitted by DISTRIBUTOR
to SUPPLIER and received electronically by SUPPLIER without data entry.

			ii.         Invoice (EDI #810): Received electronically by DISTRIBUTOR from SUPPLIER
without data entry.

			iii.         Shipment Notice (EDI #856): Transmitted by SUPPLER to DISTRIBUTOR
when shipment leaves SUPPLIER’s facility.

 

    	NATIONAL BRAND DISTRIBUTION AGREEMENT	2	 

    	 

    

 

			iv.         Price/Sales Catalogue (EDI #832): Transmitted by SUPPLER to DISTRIBUTOR
for new product adds, product deletions, invoice cost/list price changes and certain other data changes.

 

In the event SUPPLIER does not utilize all required EDI transactions
within 90 days after DISTRIBUTOR’s request that it do so, DISTRIBUTOR shall have the right thereafter to deduct 1% from its
payment of any invoices issued hereunder per each EDI transaction not implemented until SUPPLIER begins utilizing each such EDI
transaction.

 

d.           Adequately
label, package and deliver the Products. SUPPLIER shall bear all costs associated with label printing, labeling, and packaging
of the Product.

 

e.           Notify
DISTRIBUTOR immediately in writing should SUPPLIER become aware of any defect or condition which may render any of the Products
in violation of the Food, Drug and Cosmetic Act or any other applicable law.

 

f.            Make
any claims for unpaid invoices in writing within ninety (90) days of the date of SUPPLIER's first invoice for such amount. DISTRIBUTOR
will not be obligated to make payments for, or investigate, entries which are dated more than ninety (90) days before SUPPLIER's
written claim or request for investigation.

 

g.           Participate
with DISTRIBUTOR in business reviews, as mutually agreed to by the parties.

 

h.           Provide DISTRIBUTOR sales rep support and training.

 

i.            Offer DISTRIBUTOR the same promotional
opportunities afforded to other distributors of the Products

 

j.            Provide DISTRIBUTOR customer leads generated
at industry trade shows.

 

k.           Notify
the appropriate federal, state and local authorities of any customer complaints or other occurrences regarding the Products which
are required to be so reported. SUPPLIER shall be responsible for evaluating all complaints regarding the Products and for responding
to DISTRIBUTOR’s customers in writing.

 

l.           On a quarterly basis, SUPPLIER will accept
returns of product in unopened saleable full case quantities without a restocking fee.

 

m.          SUPPLIER has a purchase order minimum
of 48 sleeves (1 CS) of the PIFAâ Heparin/PF4 Rapid Assay , vendor #
4036025

 

n.           Produce
unitized pallet bar coding within one (1) year of DISTRIBUTOR's request, shipping Product unitized, shrink wrapped and on slip
sheets. In the event SUPPLIER does not ship produce unitized pallet bar coding as provided above within one year after DISTRIBUTOR’s
request that it do so, DISTRIBUTOR shall have the right thereafter to deduct a one percent (1%) administrative fee from its payment
of any invoices issued hereunder until SUPPLIER begins production thereof.

 

o.           On
or before the Effective Date, provide to DISTRIBUTOR, electronically via Excel or Access or such other format as the parties shall
agree, such competitive cross referencing information with regard to the Products as DISTRIBUTOR shall reasonably request and,
thereafter, update such information no less frequently than quarterly.

 

7.          Product
Warranties, Indemnification and Insurance. SUPPLIER specifically warrants to DISTRIBUTOR that the Products are free from
defects in design, workmanship and materials and are in compliance with the specifications and claims made by SUPPLIER for them.
SUPPLIER further agrees to execute and comply with the provisions of the Continuing Guaranty attached hereto as Exhibit 1, the
terms and conditions of which are made part hereof to the extent consistent with the terms set out in the body of this Agreement.

 

8.          Termination.
Either party shall have the right to terminate this Agreement on written notice if the other (a) commits or suffers any act of
bankruptcy or insolvency, or (b) fails to cure any material breach of the provisions of this Agreement within thirty (30) days
after written notice of such breach. In addition, each party shall have the right to terminate this Agreement, with or without
cause, upon ninety (90) days written notice to the other party.

 

    	NATIONAL BRAND DISTRIBUTION AGREEMENT	3	 

    	 

    

 

9.          Procedures
on Termination. On the termination or expiration of this Agreement, for whatever reason, SUPPLIER shall continue to honor
DISTRIBUTOR's orders for Products up to the effective date of termination and for a period of at least one (1) year thereafter,
and DISTRIBUTOR shall pay for such Products on the terms and conditions of this Agreement. In addition, SUPPLIER shall , upon DISTRIBUTOR’s
request, accept the return of any Products that have become excess or no move for full credit with no restocking fee. Excess/no
move inventory is any inventory of Products in a given distribution center that exceeds four (4) months of customer demand for
that distribution center. “Salable” Product is defined as undamaged Product in its original sealed shipping carton.

 

10.         Force
Majeure. The obligations of either party to perform under this Agreement shall be excused during each period of delay caused
by matters such as strikes, shortages of power or raw material, government orders or acts of God, which are reasonably beyond the
control of the party obligated to perform.

 

11.         Confidential
Information. SUPPLIER acknowledges and agrees that pursuant to this Agreement valuable information of a confidential nature,
which includes but is not limited to marketing, sales and new Product development information may be disclosed by DISTRIBUTOR to
SUPPLIER; that such information will be retained by SUPPLIER in confidence; and that SUPPLIER shall not, either during the term
of this Agreement or after its termination, disclose to any third party or cause anyone else to disclose to any third party confidential
information supplied to SUPPLIER by DISTRIBUTOR. Notwithstanding anything in the foregoing, the above restrictions on disclosure
shall not apply to: (a) information (other than trace sales and rebate information submitted to SUPPLIER by DISTRIBUTOR, which
shall be considered DISTRIBUTOR’s confidential information for purposes of this Agreement) which is not identified in writing
at the time of disclosure as “confidential” (or, if the information is disclosed orally, is identified at the time
of disclosure as “confidential” and is confirmed to be confidential in writing within 30 days after the date of disclosure);
(b) information which SUPPLIER can show by written evidence was known to it at the time of receipt thereof from DISTRIBUTOR; (c)
information which is subsequently obtained from sources other than DISTRIBUTOR who are not bound by a confidentiality agreement
with DISTRIBUTOR. The above restrictions shall not prohibit any disclosure which is required pursuant to a court order or administrative
proceeding; provided that SUPPLIER shall promptly notify DISTRIBUTOR of the need for any such disclosure and shall give DISTRIBUTOR
a reasonable time to oppose such process. The above restrictions shall apply during the term of this Agreement and for a period
of two years thereafter.

 

12.         Miscellaneous

 

a.           Notices.
Any notice required or permitted under this Agreement shall be in writing and shall be deemed to have been given upon receipt if
forwarded by personal delivery, certified mail, or facsimile transmission (transmission confirmed) properly addressed to the respective
parties as set forth below until notice of a different address is supplied in accordance with this Section:

 

	 	If to SUPPLIER:	 
	 	 	Akers Biosciences, Inc.
	 	 	201 Grove Road
	 	 	Thorofare, NJ  08086
	 	 	Attn:Thomas A. Nicolette, President
	 	 	Facsimile:  856.848.0269

 

    	NATIONAL BRAND DISTRIBUTION AGREEMENT	4	 

    	 

    

 

	 	If to DISTRIBUTOR:	Cardinal Health
	 	 	Medical Products and Services
	 	 	1450 Waukegan Road
	 	 	McGaw Park, IL 60085
	 	 	Attn:  Howard Jagoda, VP Supplier Relations
	 	 	Facsimile: 847-689-0366

 

b.           Entire
Agreement. This Agreement is the entire agreement between the parties hereto with regard to the subject matter of this Agreement,
there being no prior written or oral promises or representations not incorporated herein with respect to such matters.

 

c.           Applicable
Law. This Agreement shall be governed by the laws of the State of Illinois, applicable to contracts made and to be performed
in that state.

 

d.           Amendments.
No amendment or modification of the terms of this Agreement shall be binding on either party unless reduced to writing and signed
by an authorized employee of the party to be bound.

 

e.           Waiver
of Punitive Damages and Jury Trial. Both parties irrevocably waive trial by jury in any action, proceeding or counterclaim,
whether at law or in equity, brought by either of them arising out of this Agreement. Except with respect to SUPPLIER’s obligation
to indemnify DISTRIBUTOR pursuant to the Continuing Guaranty, SUPPLIER and DISTRIBUTOR waive to the fullest extent permitted by
law any right to or claim for any punitive or exemplary damages against the other and agree that, in the event of a dispute between
them regarding this Agreement, the party making a claim will be limited to equitable relief and to recovery of any actual damages
it sustains.

 

f.            Publicity.
Neither party will make any press release or other public announcement regarding this Agreement without the other party's express
prior written consent, except as required under applicable law or by any governmental agency, in which case the party required
to make the press release or public disclosure shall use commercially reasonable efforts to obtain the approval of the other party
as to the form, nature and extent of the press release or public announcement prior to issuing the press release or making the
public announcement provided that DISTRIBUTOR acknowledges that as per Transparency Directive set forth by the London Stock Exchange,
SUPPLIER must subscribe to the practice of immediate disclosure of price sensitive information and that DISTRIBUTOR will be required
to respond to any approval request for such a disclosure within 24 hours of that request.

 

13.         Assignment.
This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns,
provided, however, that neither party shall have the right to assign its interest in this Agreement without the prior written authorization
of the other party.

 

    	NATIONAL BRAND DISTRIBUTION AGREEMENT	5	 

    	 

    

 

14.         Counterparts.
For convenience of the parties hereto, this Agreement may be executed in one or more counterparts, each of which shall be deemed
an original for all purposes.

 

IN WITNESS WHEREOF, the parties have by
their duly authorized officers executed this Agreement as of the Effective Date.

 

[SUPPLIER]

 

	By:	 	 
	Title:	 	 

 

CARDINAL HEALTH 200, INC., the Medical Products 

and Services Group of Cardinal Health

 

	By:	 	 
	Title:	 	 

 

SCHEDULE “A”

 

Product Listing and Prices

 

	Vendor Mtl 
Num	 	Material Description	 	Material Desc 2	 	Purchasing 
Order 
Unit	 	Acquistion 
cost	 	Minimum 
Lot Size – 
master	 	Rounding 
Value – 
master	 
	4036025	 	RAPID ASSAY PIFA HEPARIN PLATELET FACT4	 	6TST/SL 6TST/BX 48SL/BX	 	SL	 	$	144.00	 	48	 	48	 
	4036027	 	PANEL SERUM 2 MEMBER POS AND NEG	 	DROP SHIP ONLY 2EA/BX 1BX/CS	 	CS	 	$	39.00	 	1	 	1	 
	4036028	 	PANEL SERUM 6 MEMBER 5 POS AND 1 NEG	 	DROP SHIP ONLY 6EA/BX 1BX/CS	 	CS	 	$	117.00	 	1	 	1	 
	4000124	 	DETECTOR ALCOHOL BREATHSCAN 0.04PERCENT	 	LAB PACK 100EA/BX 1BX/CS	 	CS	 	$	200.00	 	100	 	1	 
	4000128	 	DETECTOR ALCOHOL BREATHSCAN 0.08PERCENT	 	LAB PACK 100EA/BX 1BX/CS	 	CS	 	$	200.00	 	100	 	1	 

 

    	NATIONAL BRAND DISTRIBUTION AGREEMENT	6	 

    	 

    

 

EXHIBIT 1

 

Continuing Guaranty

 

THE
CG ON FILE IS TO BE USED DATED 6/1/05

 

    	NATIONAL BRAND DISTRIBUTION AGREEMENT	7	 

    	 

    

 

AMENDMENT TO NATIONAL BRAND DISTRIBUTION
AGREEMENT

 

This amendment (the “Amendment”)
is entered into effective as of June 1, 2008 by and between Cardinal Health 200, Inc. having a place
of business at 7000 Cardinal Place Dublin Ohio 43017 (hereinafter referred to as “DISTRIBUTOR”), and Akers Biosciences,
Inc., having a place of business at 201 Grove Road, Thorofare, New Jersey 08086 (hereinafter “SUPPLIER”).

 

WHEREAS, SUPPLIER and DISTRIBUTOR are parties
to a National Brand Distribution Agreement dated as of May 1, 2007 (the “Agreement”); and

 

WHEREAS, the parties wish to amend the Agreement
in certain respects.

 

NOW THEREFORE, in consideration of the mutual
promises of the parties contained herein, and for other good and valuable consideration, the parties hereby agree as follows:

 

1.            The parties agree that "PIFA Heparin / PF4 Rapid Assay
(# 4036025) and Serum Panel (#4036027, #4036028) Products” shall no longer be exclusively distributed by DISTRIBUTOR as
of the effective date of the Amendment.

 

2.            All defined terms used in this Amendment shall have the
meaning ascribed to them in the Agreement unless otherwise defined herein. All other terms and conditions of the Agreement remain
in full force and effect.

 

IN WITNESS WHEREOF, the parties hereto have caused this Amendment
to be duly executed by their duly authorized employees as of the effective date set forth above.

 

	AKERS BIOSCIENCES, INC.	 	CARDINAL HEALTH 200, INC.
	 	 	 
	By:	 	 	By:	 
	Title:	 	 	Title:	 
	Date:	 	 	Date:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00222-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00222-of-00352.parquet"}]]